βIII-Spectrin

βIII-Spectrin (Spectrin Beta Non-erythrocytic 2)

Introduction

Βiii Spectrin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-protein"> [@perkins2006]
<table> [@clarkson2010]
<tr><th>Protein Name</th><td>βIII-Spectrin</td></tr> [@zhang]
<tr><th>Gene</th><td>[SPTBN2](/genes/sptbn2)</td></tr>
<tr><th>UniProt ID</th><td>[O15020](https://www.uniprot.org/uniprot/O15020)</td></tr>
<tr><th>PDB Structure</th><td>3F5Q, 4X7Y</td></tr>
<tr><th>Molecular Weight</th><td>~272 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoskeleton, plasma membrane</td></tr>
<tr><th>Protein Family</th><td>Spectrin family</td></tr>
</table>
</div>

Structure

βIII-spectrin is a large cytoskeletal protein composed of:

Domain Organization

• N-terminal actin-binding domain: Binds to junctional complexes
• Spectrin repeat region: 17 spectrin repeats (α-helical)
• PH domain: Phosphoinositide binding
• C-terminal domain: Dimerization and membrane association

Structural Features

• Spectrin repeats: 17-20 triple-helical repeats
• EF-hand calcium-binding motifs: Regulation of stability
• Ankyrin-binding site: Membrane anchoring
• Phosphorylation sites: Multiple regulatory sites

Normal Function

βIII-spectrin provides structural stability and organization:

βIII-Spectrin (Spectrin Beta Non-erythrocytic 2)

Introduction

Βiii Spectrin is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

<div class="infobox infobox-protein"> [@perkins2006]
<table> [@clarkson2010]
<tr><th>Protein Name</th><td>βIII-Spectrin</td></tr> [@zhang]
<tr><th>Gene</th><td>[SPTBN2](/genes/sptbn2)</td></tr>
<tr><th>UniProt ID</th><td>[O15020](https://www.uniprot.org/uniprot/O15020)</td></tr>
<tr><th>PDB Structure</th><td>3F5Q, 4X7Y</td></tr>
<tr><th>Molecular Weight</th><td>~272 kDa</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoskeleton, plasma membrane</td></tr>
<tr><th>Protein Family</th><td>Spectrin family</td></tr>
</table>
</div>

Structure

βIII-spectrin is a large cytoskeletal protein composed of:

Domain Organization

• N-terminal actin-binding domain: Binds to junctional complexes
• Spectrin repeat region: 17 spectrin repeats (α-helical)
• PH domain: Phosphoinositide binding
• C-terminal domain: Dimerization and membrane association

Structural Features

• Spectrin repeats: 17-20 triple-helical repeats
• EF-hand calcium-binding motifs: Regulation of stability
• Ankyrin-binding site: Membrane anchoring
• Phosphorylation sites: Multiple regulatory sites

Normal Function

βIII-spectrin provides structural stability and organization:

Neuronal Functions

• Membrane skeleton: Stabilizes plasma membrane
• Protein anchoring: Links membrane proteins to actin
• Synapse organization: Maintains postsynaptic density
• Organelle trafficking: Vesicular transport support

Cerebellar Purkinje Cells

• Highest expression in CNS
• Essential for dendritic arborization
• Maintains synaptic contacts
• Supports long-term depression (LTD)

Role in Disease

Spinocerebellar Ataxia Type 5 (SCA5)

SPTBN2 mutations cause SCA5:

Pathogenic Mechanisms:

• Loss of βIII-spectrin function
• Impaired Purkinje cell development
• Disrupted synaptic plasticity
• Progressive cerebellar degeneration

• Gene therapy for functional protein delivery
• Neuroprotective strategies
• Supportive care for symptoms

Therapeutic Targeting

Gene Therapy Approaches

• AAV-delivered wild-type SPTBN2
• BAC-based gene therapy
• CRISPR-mediated gene correction

Neuroprotective Strategies

• Support Purkinje cell survival
• Enhance cytoskeletal stability
• Modulate synaptic function

Key Publications

Clinical Presentation

SCA5 has characteristic features:

Core Symptoms

• Progressive cerebellar ataxia
• Gait instability and coordination deficits
• Dysarthria (slurred speech)
• Nystagmus (involved eye movements)
• Difficulty with fine motor tasks

Additional Features

• Intention tremor
• Hyperreflexia in some cases
• Mild cognitive impairment possible
• Slow disease progression

Disease Course

• Age of onset: Typically 20-40 years
• Variable progression rate
• May remain ambulatory for decades
• Life expectancy usually normal

Research Directions

Current Studies

• Understanding spectrin function in [neurons](/entities/neurons)
• Developing gene therapy vectors
• Biomarker development
• Natural history studies

Model Systems

• SPTBN2 knockout mice
• Zebrafish models
• Patient-derived neurons
• Drosophila models

Protein Interactions

βIII-spectrin interacts with key proteins:

| Partner | Interaction | Function |
|---------|-------------|----------|
| αII-spectrin (SPTAN1) | Heterodimer | Membrane skeleton |
| Ankyrin-G | Binding | Membrane anchoring |
| Actin | Binding | Cytoskeletal linkage |
| Na+/K+ ATPase | Anchoring | Ion channel organization |
| GABA receptors | Scaffolding | Synaptic organization |

Pathogenic Mechanisms

Loss of Function

• Reduced protein stability
• Impaired membrane targeting
• Cytoskeletal disruption
• Synaptic dysfunction

Cellular Effects

• Purkinje cell degeneration
• Dendritic arbor loss
• Synaptic plasticity defects
• Axonal transport impairment

Background

The study of Βiii Spectrin has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[@zhang]: Zhang Y,

See Also

• SPTBN2 Gene - Gene Page
• [Spinocerebellar Ataxia](/diseases/spinocerebellar-ataxia) Disease
• Cerebellar Purkinje Cells - Cell Type
• Cytoskeletal Dynamics -

External Links

• [UniProt: O15020](https://www.uniprot.org/uniprot/O15020)
• [RCSB PDB: 3F5Q](https://www.rcsb.org/structure/3F5Q)
• [GeneReviews: SCA5](https://www.ncbi.nlm.nih.gov/books/NBK1318/)